MedPath

Investigating the effect of diclofenac suppository on nausea and vomiting

Phase 3
Conditions
ausea and vomiting.
Nausea and vomiting
Registration Number
IRCT20200606047664N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients required IMF post maxillofacial surgeries

Exclusion Criteria

pregnancy
coaglupathy disfunction
heart, liver, kidney and gasterointestinal disease history
addiction history

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea. Timepoint: after recovery, 6 hours post operation, 12 hours post operation. Method of measurement: According to the questionnaire using symptom of nausea.;Vomiting. Timepoint: after recovery, 6 hours post operation, 12 hours post operation. Method of measurement: According to the questionnaire using sign of vomiting.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath